FindTrial
Sign In

Treatment of benign orbital apex lesion with orbital decompression combined with intralesional injection of bleomycin

Treatment of benign orbital apex lesion with orbital decompression combined with intralesional injection of bleomycin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-16010261
Enrollment
Unknown
Registered
2016-12-26
Start date
2016-12-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign orbital apex lesion

Interventions

decompression combined with intralesional injection:orbital decompression and intralesional injection of bleogmycin
tumor resection:tumor resection

Sponsors

Eye and ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed of orbital apex lesion; 2. Male or female aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1. Diagnosed of malignant lesion; 2. Accompanied by other eye diseases which probably compromise visual acuity, e.g. glaucoma, cataract, diabetic retinopathy etc.; 3. Having ever received other orbital surgery.

Design outcomes

Primary

MeasureTime frame
best corrected visual acuiuy;Humphrey static vision field;VEP;orbital MRI image;orbital CT image;RNFL;Hue 100 test;macular OCT;—

Secondary

MeasureTime frame
pupillary light reflex;—

Countries

China

Contacts

Public ContactJiang Qian

Eye and ENT Hospital of Fudan University

qianjiang58@126.com+86 13801835100

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026